Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study

Lung Cancer

Volumn 89, Issue 3, 2015, Pages 350-356

  Ferrero, Cinzia ^a   Badellino, Serena ^b   Filippi, Andrea Riccardo ^b   Focaraccio, Luana ^b   Giaj Levra, Matteo ^b   Levis, Mario ^b   Moretto, Francesco ^b   Torchio, Roberto ^a   Ricardi, Umberto ^b   Novello, Silvia ^b  

^a SAN LUIGI GONZAGA HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Early stage; Lung cancer; Pulmonary function; Radiation pneumonitis; Stereotactic ablative radiotherapy; Stereotactic body radiotherapy

Indexed keywords

OXYGEN;

ABLATION THERAPY; ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; ASTHENIA; BLOOD PRESSURE; BREATHING; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG CANCER SYMPTOM SCALE QUESTIONNAIRE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG TOXICITY; MALE; NON SMALL CELL LUNG CANCER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION DOSE; RADIATION PNEUMONIA; RADIATION THERAPY ONCOLOGY GROUP SCORING SYSTEM; SCORING SYSTEM; SLOW VITAL CAPACITY; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC TREATMENT; THORAX PAIN; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RADIOSURGERY; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOSURGERY; RESPIRATORY FUNCTION TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84938744786     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2015.06.019     Document Type: Article

References (28)

1. Vansteenkiste J., Crino L., Dooms C., Douillard J.Y., Faivre-Finn C., Lim E., et al. 2nd ESMO consensus conference on lung cancer: early-stage non-small-cell lung cancer consensus on diagnosis treatment and followup. Ann. Oncol. 2014, 25:1462-1474.
2. Baumann P., Nyman J., Hoyer M., Wennberg B., Gagliardi G., Lax I., et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J. Clin. Oncol. 2009, 27:3290-3296.
3. Fakiris A.J., McGarry R.C., Yiannoutsos C.T., Papiez L., Williams M., Henderson M.A., et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int. J. Radiat. Oncol. Biol. Phys. 2009, 75:677-682.
4. Bral S., Gevaert T., Linthout N., Versmessen H., Collen C., Engels B., et al. Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial. Int. J. Radiat. Oncol. Biol. Phys. 2011, 80:1343-1349.
5. Ricardi U., Filippi A.R., Guarneri A., Giglioli F.R., Ciammella P., Franco P., et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer 2010, 68:72-77.
6. Timmerman R., Paulus R., Galvin J., Michalski J., Straube W., Bradley J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076.
7. Ricardi U., Frezza G., Filippi A.R., Badellino S., Levis M., Navarria P., et al. Stereotactic ablative radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study. Lung Cancer 2014, 84:248-253.
8. Baumann P., Nyman J., Hoyer M., Gagliardi G., Lax I., Wennberg B., et al. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer: first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother. Oncol. 2008, 88:359-367.
9. Stephans K.L., Djemil T., Reddy C.A., Gajdos S.M., Kolar M., Machuzak M., et al. Comprehensive analysis of pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J. Thorac. Oncol. 2009, 4:838-844.
10. Stanic S., Paulus R., Timmerman R.D., Michalski J.M., Barriger R.B., Bezjak A., et al. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early-stage peripheral non-small cell lung cancer: an analysis of RTOG 0236. Int. J. Radiat. Oncol. Biol. Phys. 2014, 88:1092-1099.
11. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardization of spirometry. Eur. Respir. J. 2005, 26:319-338.
12. Macintyre N., Crapo R.O., Viegi G., Johnson D.C., van der Grinten C.P., Brusasco V., et al. Standardization of the single breath determination of carbon monoxide uptake in the lung. Eur. Respir. J. 2005, 26:720-735.
13. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., Yernault J.C. Standardized lung function testing. Eur. Respir. J. 1993, 6(Suppl):1-99.
14. Ricardi U., Filippi A.R., Guarneri A., Giglioli F.R., Mantovani C., Fiandra C., et al. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy. Acta Oncol. 2009, 27:1-7.
15. Benedict S.H., Yenice K.M., Followill D., Galvin J.M., Hinson W., Kavanagh B., et al. Stereotactic body radiation therapy: the report of AAPM task group 101. Med. Phys. 2010, 37:4078-4101.
16. Kimura T., Matsuura K., Murakami Y., Hashimoto Y., Kenjo M., Kaneyasu Y., et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers?. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66:483-491.
17. Palma D.A., Senan S., Haasbeek C.J., Verbakel W.F., Vincent A., Lagerwaard F. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques. Int. J. Radiat. Oncol. Biol. Phys. 2011, 80:506-513.
18. Koenig T.R., Munden R.F., Erasmus J.J., Sabloff B.S., Gladish G.W., Komaki R., et al. Radiation injury of the lung after three-dimensional conformal radiation therapy. Am. J. Roentgenol. 2002, 178(6):1383-1388.
19. Hollen P.J., Gralla R.J., Kris M.G., Cox C., Belani C.P., Grunberg S.M., et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the lung cancer symptom scale. Cancer 1994, 73:2087-2098.
20. Louie Av Palma D.A., Dahele M., Rodrigues G.B., Senan S. Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons. Radiother. Oncol. 2015, 114:138-147.
21. Brada M., Pope A., Baumann M. SABR in NSCLC-the beginning of the end or the end of the beginning. Radiother. Oncol. 2015, 114:135-137.
22. Guckenberger M., Kestin L.L., Hope A.J., Belderbos J., Werner-Wasik M., Yan D., et al. Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer?. J. Thorac. Oncol. 2012, 7:542-551.
23. Henderson M., McGarry R., Yiannoutsos C., Fakiris A., Hoopes D., Williams M., et al. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72:404-409.
24. Stephans K.L., Djemil T., Reddy C.A., Gajdos S.M., Kolar M., Machuzak M., et al. Comprehensive analysis of pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J. Thorac. Oncol. 2009, 4:838-844.
25. Ong C.L., Palma D., Verbakel W.F., Slotman B.J., Senan S. Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity. Radiother. Oncol. 2010, 97:431-436.
26. Lagerwaard F.J., Aaronson N.K., Gundy C.M., Haasbeek C.J., Slotman B.J., Senan S. Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer. J. Thorac. Oncol. 2012, 7:1148-1154.
27. van der Voort van Zyp N.C., Prévost J.B., van der Holt B., Braat C., van Klaveren R.J., Pattynama P.M., et al. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J. Radiat. Oncol. Biol. Phys. 2010, 77:31-37.
28. Widder J., Postmus D., Ubbels J.F., Wiegman E.M., Langendijk J.A. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Int. J. Radiat. Oncol. Biol. Phys 2011, 81:e291-7.